Management of HELLP syndrome;Prise en charge du HELLP syndrome

Gynecologie Obstetrique et Fertilite

Volumn 36, Issue 12, 2008, Pages 1175-1190

  Beucher, G ^a   Simonet, T ^a   Dreyfus, M ^a  

^a CAEN UNIVERSITY HOSPITAL   (France)

Author keywords

HELLP syndrome; Preeclampsia; Pregnancy; Prognosis

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; AMINOTRANSFERASE; ANTIHYPERTENSIVE AGENT; BETAMETHASONE; BILIRUBIN; CORTICOSTEROID; DEXAMETHASONE; HYDRALAZINE; LABETALOL; LACTATE DEHYDROGENASE; MAGNESIUM SULFATE; METHYLDOPA; NICARDIPINE; ORAL CONTRACEPTIVE AGENT; PREDNISOLONE;

ABDOMINAL PAIN; ACUTE KIDNEY FAILURE; ARTICLE; BILIRUBIN BLOOD LEVEL; CESAREAN SECTION; CORTICOSTEROID THERAPY; DIFFERENTIAL DIAGNOSIS; DISSEMINATED INTRAVASCULAR CLOTTING; ECLAMPSIA; HELLP SYNDROME; HEMOLYSIS; HOSPITAL; HUMAN; INTENSIVE CARE UNIT; LIVER DYSFUNCTION; LIVER HEMATOMA; LUNG EDEMA; MATERNAL MORBIDITY; MATERNAL MORTALITY; NEWBORN DISEASE; PREECLAMPSIA; PREGNANCY TERMINATION; PREMATURITY; PROGNOSIS; PUERPERIUM; RECURRENT DISEASE; SOLUTIO PLACENTAE; THIRD TRIMESTER PREGNANCY; THROMBOCYTE COUNT; THROMBOCYTOPENIA; VAGINAL DELIVERY; VOMITING;

EID: 57049146794     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2008.08.015     Document Type: Article

References (123)

1. Weinstein L. Syndrome of hemolysis, elevated liver enzymes and low platelet count: a severe consequence of hypertension in pregnancy. Am J Obstet Gynecol 142 (1982) 159-167
2. Sibaï B.M. The HELLP syndrome (hemolysis, elevated liver enzymes and low platelets): Much ado about nothing?. Am J Obstet Gynecol 162 (1990) 311-316
3. Réanimation des formes graves de pré-éclampsie. Conférence d'experts. Eds Pottecher T, Launoy A. Collection de la SFAR, Éditions Elsevier, Paris, 2008.
4. Martin Jr. J.N., Rinehart B., May W.L., Magann E.F., Terrone D.A., and Blake P.G. The spectrum of severe preeclampsia: comparative analysis by HELLP (hemolysis, elevated liver enzymes levels, and low platelet count) syndrome classification. Am J Obstet Gynecol 180 (1999) 1373-1384
5. Audibert F., Friedman S.A., Frangieh A.Y., and Sibaï B.M. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 175 (1996) 460-464
6. Boulanger H., and Flamant M. Avancées récentes dans la compréhension de la physiopathologie de la prééclampsie et conséquences thérapeutiques potentiels. Nephrol Ther 3 (2007) 437-448
7. Tsatsaris V., Fournier T., and Winer N. Physiopathologie de la prééclampsie. J Gynecol Obstet Reprod Biol 37 (2008) 16-23
8. Tranquilli A.L., Landi B., Corradetti A., Giannubilo S.R., Sartini D., Pozzi V., et al. Inflammatory cytokines patterns in the placenta of pregnancies complicated by HELLP (hemolysis, elevated liver enzyme, and low platelet) syndrome. Cytokine 40 (2007) 82-88
9. VanWijk M.J., Kublickiene K., Boer K., and VanBavel E. Vascular function in preeclampsia. Cardiovascular Research 47 (2000) 38-48
10. Robinson C.J., and Johnson D.D. Soluble endoglin as a second-trimester marker for preeclampsia. Am J Obstet Gynecol 197 174 (2007) e1-e5
11. Levine R.J., Lam C., Quian C., Yu K.F., Maynard S.E., Sachs B.P., et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med 355 (2006) 992-1005
12. Venkatesha S., Toporsian M., Lam C., Hanai J., Mammoto T., Kim Y.M., et al. Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med 12 (2006) 642-649
13. Strand S., Strand D., Seufert R., Mann A., Lotz J., Blessing M., et al. Placenta-derived CD95 ligand causes liver damage in HELLP syndrome. Gastroenterology 126 (2004) 849-858
14. Baxter J.K., and Weinstein L. HELLP syndrome: The state of the art. Obstet Gynecol Surv 59 (2004) 838-845
15. Barton J.R., Riely C.A., Adame T.A., Shanklin D.R., Khoury A.D., and Sibai B.M. Hepatic histopathologic condition does not correlate with laboratory abnormalities in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 167 (1992) 1538-1543
16. Pauzner R., Dulitzky M., Carp H., Mayan H., Kenett R., Farfel Z., et al. Hepatic infarctions during pregnancy are associated with the antiphospholipid syndrome and in addition with complete or incomplete HELLP syndrome. J Thromb Haemost 1 (2003) 1758-1763
17. Haram K., Trovik J., Sandset P.M., and Hordnes K. Severe HELLP syndrome in the 18th week of pregnancy associated with the antiphospholipid-antibody syndrome. Acta Obstet Gynecol Scand 82 (2003) 679-680
18. Thuong D.L.T., Tieulie' N., Costedoat N., Andreu M.-R., Wechsler B., Vauthier-Brouzes D., et al. The HELLP syndrome in the antophospholipid syndrome: retrospective study of 16 cases in 15 women. Ann Rheum Dis 64 (2005) 273-278
19. Koenig M., Roy M., Baccot S., Cuilleron M., de Filippis J.-P., and Cathebras P. Thrombotic microangiopathy with liver, gut, and bone infarction (catastrophic antiphospholipid syndrome) associated with HELLP syndrome. Clin Rheum 24 (2005) 166-168
20. Benedetto C., Marozio L., Salton L., Maula V., Chieppa G., and Massobrio M. Factor V Leiden and factor II G20210A in preeclampsia and HELLP syndrome. Acta Obstet Gynecol Scand 81 (2002) 1095-1100
21. Bozzo M., Carpani G., Leo L., Marcozzi S., Sacchi E., Morono G., et al. HELLP syndrome and factor V Leiden. Eur J Obstet Gynecol Reprod Biol 95 (2001) 55-58
22. Van Pampus M.G., Folf H., Koopman M.M., van den Ende A., Butler H.R., and Reitsma P.H. Prothrombin 20210G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and HELLP syndrome. Hypertens Pregnancy 20 (2001) 291-298
23. Schlembach D., Beinder E., Zingsem J., Wunsiedler U., Beckmann M.W., and Fischer T. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction. Clin Sci 105 (2003) 279-285
24. Queyrel V., Ducloy-Bouthors A.S., Michon-Pasturel U., Hachulla E., Dubuequoi S., Caron C., et al. Antiphospholipid antibodies in HELLP syndrome: clinical and biological study in 68 women. Rev Med Interne 24 (2003) 158-164
25. Sibaï B.M., Ramadan M.K., Usta I., Salama M., Mercer B.M., and Friedman S.A. Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome). Am J Obstet Gynecol 169 (1993) 1000-1006
26. Sibai B.M., and Barton J.R. Expectant management of severe preeclampsia remote from term: patient selection, treatment and delivery indications. Am J Obstet Gynecol 196 514. (2007) e1-e9
27. Miles Jr. J.F., Martin Jr. J.N., Blake P.G., Perry Jr. K.G., Martin R.W., and Meeks G.R. Postpartum eclampsia: a recurring perinatal dilemma. Obstet Gynecol 76 (1990) 328-331
28. Martin Jr. J.N., Perry Jr. K.G., Miles Jr. J.F., Blake P.G., Magann E.F., Roberts W.E., et al. The interrelationship of eclampsia, HELLP syndrome and prematurity: cofactors for significant maternal and perinatal risk. Br J Obstet Gynaecol 100 (1993) 1095-1100
29. Vigil-De Gracia P. Pregnancy complicated by pre-eclampsia-eclampsia with HELLP syndrome. Int J Gynecol Obstet 72 (2001) 17-23
30. Haddad B., Barton J.R., Livingston J.C., Chahine R., and Sibai B.M. Risk factors for adverse maternal outcomes among women with HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 183 (2000) 444-448
31. Martin Jr. J.N., Blake P.G., Perry Jr. K.G., McCaul J.F., Hess L.W., and Martin R.W. The natural history of HELLP syndrome: patterns of disease progression and regression. Am J Obstet Gynecol 164 (1991) 1500-1513
32. Sibai B.M. Diagnosis, controversies and management of the syndrome of hemolysis, elevated liver enzymes and low platelet count. Obstet Gynecol 103 (2004) 981-991
33. Weinstein L. Preeclampsia/eclampsia with hemolysis, elevated liver enzymes and thrombocytopenia. Obstet Gynecol 66 (1985) 657-660
34. Martin Jr. J.N., Rose C.H., and Briery C.M. Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child. Am J Obstet Gynecol 195 (2006) 914-934
35. Wilke G., Rath W., Schutz E., Armstrong V.W., and Kuhn W. Haptoglobin as a sensitive marker of hemolysis in HELLP-syndrome. Int J Gynaecol Obstet 39 (1992) 29-34
36. Martin Jr. J.N., Blake P.G., Lowery S.L., Perry K.G., Files J.C., and Morrison J.C. Pregnancy complicated by preeclampsia-eclampsia with HELLP syndrome: how rapid is postpartum recovery?. Obstet Gynecol 76 (1990) 737-741
37. Katz V.L., Thorp Jr. J.M., Rozas L., and Bowes Jr. W.A. The natural history of thrombocytopenia associated with preeclampsia. Am J Obstet Gynecol 163 (1990) 1142-1143
38. Neiger R., Contag S.A., and Coustan D.R. The resolution of preeclampsia related thrombocytopenia. Obstet Gynecol 77 (1991) 692-695
39. Makkonen N., Harju M., and Kirkinen P. Postpartum recovery after severe preeclampsia and HELLP syndrome. J Perinat Med 24 (1996) 641-649
40. Rychel V., and Williams K.P. Correlation of platelet count changes with liver cell destruction in HELLP syndrome. Hypertens Pregnancy 22 (2003) 57-61
41. Sibai B.M. Imitators of severe preeclampsia. Obstet Gynecol 109 (2007) 956-966
42. Usta I.M., Barton J.R., Amon E.A., Gonzalez A., and Sibai B.M. Acute fatty liver of pregnancy: An experience in the diagnosis and management of fourteen cases. Am J Obstet Gynecol 171 (1994) 1342-1347
43. Castro M.A., Fassett M.J., Reynolds T.B., Shaw K.J., and Goodwin T.M. Reversible peripartum liver failure: A new perspective on the diagnosis, treatment, and cause of acute fatty liver of pregnancy, based on 28 consecutive cases. Am J Obstet Gynecol 181 (1999) 389-395
44. Vigil-De Gracia P., and Lavergne J.A. Acute fatty liver of pregnancy. Int J Gynaecol Obstet 72 (2001) 193-195
45. Fesenmeier M.F., Coppage K.H., Lambers D.S., Barton J.R., and Sibai B.M. Acute fatty liver of pregnancy in 3 tertiary care centers. Am J Obstet Gynecol 192 (2005) 1416-1419
46. Proia A., Paesano R., Torcia F., Annino L., Capria S., Ferrari A., et al. Thrombotic thrombocytopenic purpura and pregnancy: A case report and a review of the literature. Ann Hematol 81 (2002) 210-214
47. Rehberg J.F., Briery C.M., Hudson W.T., Bofill J.A., and Martin Jr. J.N. Thrombotic thrombocytopenic purpura masquerading as hemolysis, elevated liver enzymes, low platelets (HELLP) syndrome in late pregnancy. Obstet Gynecol 108 (2006) 817-820
48. George J.N. Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 354 (2006) 1927-1935
49. Moake J.L. Thrombotic microangiopathies. N Engl J Med 347 (2002) 589-600
50. Chakravarty E.F., Colon I., Langen E.S., Nix D.A., El-Sayed Y.Y., Genovese M.C., et al. Factors that predict prematurity and preeclampsia in pregnancies that are complicated by systemic lupus erythematosus. Am J Obstet Gynecol 192 (2005) 1897-1904
51. Egerman R.S., Ramsey R.D., Kao L.W., Bringman J.J., Bush A.J., and Wan J.Y. Hypertensive disease in pregnancies complicate by systemic lupus erythematosus. Am J Obstet Gynecol 193 (2005) 1676-1679
52. Dhar J.P., Essenmacher L.M., Ager J.W., and Sokol R.J. Pregnancy outcomes before and after a diagnosis of systemic lupus erythematosus. Am J Obstet Gynecol 193 (2005) 1444-1455
53. Tincani A., Bompane D., Danieli E., and Doria A. Pregnancy, lupus and antiphospholipid syndrome (Hughes Syndrome). Lupus 15 (2006) 156-160
54. Levine J.S., Branch D.W., and Rauch J. The antiphospholipid syndrome. N England J Med 346 (2002) 752-763
55. Isler C.M., Rinehart B.K., Terrone D.A., Martin R.W., Magann E.F., and Martin Jr. J.N. Maternal Mortality associated with HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 181 (1999) 924-928
56. Cavkaytar S., Ugurlu E.N., Karaer A., Tapisiz O.L., and Danisman N. Are clinical symptoms more predictive than laboratory parameters for adverse maternal outcome in HELLP syndrome?. Acta Obstet Gynecol Scand 86 (2007) 648-651
57. Witlin A.G., Saade G.R., Mattar F., and Sibai B.M. Risk factors for abruptio placentae and eclampsia: analysis of 445 consecutively managed women with severe preeclampsia and eclampsia. Am J Obstet Gynecol 180 (1999) 1322-1329
58. Sibai B.M., and Ramadan M.K. Acute renal failure in pregnancies complicated by hemolysis, elevated liver enzymes and low platelets. Am J Obstet Gynecol 168 (1993) 1682-1690
59. Drakeley A.J., Le Roux P.A., Anthony J., and Penny J. Acute renal failure complicating severe preeclampsia requiring admission to an obstetric intensive care unit. Am J Obstet Gynecol 186 (2002) 253-256
60. Woods J.B., Blake P.G., Perry Jr. K.G., Magann E.F., Martin R.W., and Martin Jr. J.N. Ascites: a portent of cardiopulmonary complications in the preeclamptic patient with the syndrome of hemolysis, elevated liver enzymes, and low platelets. Obstet Gynecol 80 (1992) 87-91
61. Matar N., Morsad M., Ghazli M., Abassi H., Harti A., Chraibi T., et al. Hématome sous-capsulaire du foie. À propos de 6 cas et revue de la littérature. J Gynecol Obstet Biol Reprod 25 (1996) 89-93
62. Peitz U., Labenz J., and Börsch G. Sonographic findings of liver and gallbladder in early hemolysis, elevated liver enzymes, and low platelet count syndrome. J Clin Ultrasound 21 (1993) 557-560
63. Chan A.D.S., and Gerscovich E.O.G. Imaging of subcapsular hepatic and renal hematomas in pregnancy complicated by preeclampsia and the HELLP syndrome. J Clin Ultrasound 27 (1999) 35-40
64. Barton J.R., and Sibai B.M. Hepatic imaging in HELLP syndrome (hemolysis, elevated liver enzymes, and low platelet count). Am J Obstet Gynecol 174 (1996) 1820-1827
65. Sheikh R.A., Yasmeen S., Pauly M.P., and Riegler J.L. Spontaneous intrahepatic hemorrhage and hepatic rupture in the HELLP syndrome. Four cases and a review. J Clin Gastroenterol 28 (1999) 323-328
66. Seren G., Morel J., Jospe R., Mahul P., Dumont A., Cuileron M., et al. HELLP syndrome et hématome sous-capsulaire du foie rompu. Stratégie thérapeutique à partir d'un cas clinique. Ann Fr Anesth Reanim 25 (2006) 1067-1069
67. Wicke C., Pereira P.L., Neeser E., Flesch I., Rodegerdts E.A., and Becker H.D. Subcapsular liver hematoma in HELLP syndrome: Evaluation of diagnostic and therapeutic options: a unicenter study. Am J Obstet Gynecol 190 (2004) 106-112
68. Visser W., and Wallenburg H.C.S. Temporising management of severe pre-eclampsia with and without the HELLP syndrome. Br J Obstet Gynaecol 102 (1995) 111-117
69. Abramovici D., Friedman S.A., Mercer B.M., Audibert F., Kao L., and Sibai B.M. Neonatal outcome in severe preeclampsia at 24 to 36 weeks' gestation: does the HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome matter?. Am J Obstet Gynecol 180 (1999) 221-225
70. Van Pampus M.G., Wolf H., Westenberg S.M., Van Der Post J.A., Bonsel G.J., and Treffers P.E. Maternal and perinatal outcome after expectant management of the HELLP syndrome compared with preeclampsia without HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 76 (1998) 31-36
71. Van Pampus Mg, Wolf H., Ilsen A., and Treffers P.E. Maternal outcome following temporizing management of the (H)ELLP syndrome. Hypertens Pregnancy 19 (2000) 211-220
72. Haddad B., Barton J.R., Livingston J.C., Chahine R., and Sibai B.M. HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome versus severe preeclampsia: Onset at <28.0 weeks' gestation. Am J Obstet Gynecol 183 (2000) 1475-1479
73. Raval D.S., Co S., Reid M.A., and Pildes R. Maternal and neonatal outcome of pregnancies complicated with maternal HELLP syndrome. J Perinatol 17 (1997) 266-269
74. Kändler C., Kevekordes B., Zenker M., Kandler M., Beinder E., Lang N., et al. Prognosis of children born to mothers with HELLP-syndrome. J Perinat Med 26 (1998) 486-490
75. Clark S.L., Phelan J.R., Allen S.H., and Golde S.R. Antepartum reversal of hematologic abnormalities associated with the HELLP syndrome. J Reprod Med 32 (1987) 781-784
76. Heyborne K.D., Burke M.S., and Porreca R.P. Prolongation of premature gestation in women with hemolysis, elevated liver enzymes and low platelets. J Reprod Med 35 (1990) 53-57
77. Heller C.S., and Elliott J.P. High-order multiple pregnancies complicated by HELLP syndrome: a report of four cases with corticosteroid therapy to prolong gestation. J Reprod Med 42 (1997) 743-746
78. Visser W., and Wallenburg H.C.S. Maternal and perinatal outcome of temporizing management in 254 consecutive patients witn severe pre-eclampsia remote from term. Eur J Obstet Gynecol Reprod Biol 63 (1995) 147-154
79. Tsatsaris V., Carbonne B., La Tour M.D., Cabrol D., and Milliez J. Is conservative treatment of HELLP syndrome safe?. Eur J Obstet Gynecol Reprod Biol 80 (1998) 139-141
80. Redman C.W.G., and Sargent I.L. Preeclampsia and the systemic inflammtory response. Semin Nephrol 24 (2004) 565-570
81. van Runnard Heimel P.J., Franx A., Schobben A.F.A.M., Huisjes A.J.M., Derks J.B., and Bruinse H.W. Corticosteroids, pregnancy and HELLP syndrome: a review. Obstet Gynecol Surv 60 (2004) 57-70
82. Amorium M.M.R., Santas L.C., and Faundes A. Corticosteroid therapy for prevention of respiratory distress syndrome in severe preeclampsia. Am J Obstet Gynecol 180 (1999) 1283-1288
83. Crowley P. Prophylactic corticosteroids for preterm birth. Cochrane Database Syst Rev 2007, Issue 4, CD000065.
84. Thiagarajah S., Bourgeois F.S., Harbert G.M., and Caudle M.R. Thrombocytopenia in preeclampsia: associated abnormalities and management principles. Am J Obstet Gynecol 150 (1984) 1-7
85. Clark S.L., Phelan J.R., Allen S.H., and Golde S.R. Antepartum reversal of hematologic abnormalities associated with the HELLP syndrome. A report of three cases. J Reprod Med 31 (1986) 70-72
86. Magann E.F., Martin R.W., Issacs J.D., Blake P.G., Morrison J.C., and Martin Jr. J.N. Corticosteroids for the enhancement of fetal lung maturity: impact on the gravida with preeclampsia and the HELLP syndrome. Aust N Z J Obstet Gynaecol 33 (1993) 127-131
87. Yeast J.D., and Coronado S. Hepatic dysfunction, thrombocytopenia and late onset preeclampsia. A report of three cases. J Reprod Med 32 (1987) 781-784
88. Martin Jr. J.N., Perry Jr. K.G., Blake P.G., et al. Better maternal outcomes are achieved with dexamethasone therapy for postpartum HELLP (hemolysis, elevated liver enzymes, and thrombocytopenia) syndrome. Am J Obstet Gynecol 177 (1997) 1011-1017
89. Tompkins M.J., and Thiagarajah S. HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome: the benefit of corticosteroids. Am J Obstet Gynecol 181 (1999) 304-309
90. Dreyfus M., Tissier I., Ndocko M.A., Denoual I., Baldauf J.J., and Ritter J. Corticosteroid therapy for conservative management in marginally viable pregnancy complicated by HELLP syndrome. Eur J Obstet Gynecol Reprod Biol 85 (1999) 233-234
91. O'Brien J.M., Milligan D.A., and Barton J.R. Impact of high-dose corticosteroid therapy for patients with HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome. Am J Obstet Gynecol 183 (2000) 921-924
92. O'Brien J.M., Shumate S.A., Satchwell S.L., Milligan D.A., and Barton J.R. Maternal benefit to corticosteroid therapy in patients with HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome: impact on the rate of regional anesthesia. Am J Obstet Gynecol 186 (2002) 475-479
93. Crane J.M.G., Tabarsi B., and Hutchens D. The maternal benefits of corticosteroids with HELLP (hemolysis, elevated liver enzymes and low platelet count) syndrome. J Obstet Gynaecol Can 25 (2003) 650-655
94. Isler C.M., Magann E.F., Rinehart B.K., Terrone D.A., Bass J.D., and Martin Jr. J.N. Dexamethasone compared with betamethasone for glucocorticoid treatment of postpartum HELLP syndrome. Int J Gynaecol Obstet 80 (2003) 291-297
95. Martin Jr. J.N., Thigsen B.D., Rose C.H., Cushman J., Moore, and May W.L. Maternal benefit of high-dose intravenous corticosteroid therapy for HELLP. Am J Obstet Gynecol 189 (2003) 830-834
96. Matchaba P, Moodley J. Corticosteroids for HELLP syndrome in pregnancy. Cochrane Database Syst Rev 2007, Issue 4, CD002076.
97. Magann E.F., Bass D., Chauhan S.P., Perry Jr. K.G., Sullivan D.L., and Martin Jr. J.N. Antepartum corticosteroids: disease stabilization in patients wiith the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 171 (1994) 1148-1153
98. Magann E.F., Perry Jr. K.G., Meydrech E.F., Harris R.L., Chauhan S.P., and Martin Jr. J.N. Postpartum corticosteroids: accelerated recovery from the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP). Am J Obstet Gynecol 171 (1994) 1154-1158
99. Vigil-DeGracia P., and Garcia-Caceres E. Dexamethasone in the post-partum treatment of HELLP syndrome. Int J Gynaecol Obstet 59 (1997) 217-221
100. Yalcin O.T., Sener T., Hassa H., Ozalp S., and Okur A. Effects of postpartum corticosteroids in patients with HELLP syndrome. Int J Gynaecol Obstet 61 (1998) 141-148
101. Isler C.M., Barrilleaux P.S., Magann E.F., Bass D., and Martin Jr. J.N. A prospective, randomized trial comparing the efficacy of dexamethasone and betamethasone for the treatment of antepartum HELLP (hemolysis, elevated liver enzymes, and low platelet count) syndrome. Am J Obstet Gynecol 184 (2001) 1332-1337
102. Fonseca J.E., Mendez F., Catano C., and Arias F. Dexamethasone treatment does not improve the outcome of women with HELLP syndrome: a double-blind, placebo-controlled, randomized clinical trial. Am J Obstet Gynecol 193 (2005) 1591-1598
103. Van Runnard Heimel P.J., Schobben A.F., Huisjes A.J., Franx A., and Bruinse H.W. The transplacental passage of prednisolone in pregnancies complicated by early-onset HELLP syndrome. Placenta 26 (2005) 842-845
104. Van Runnard Heimel P.J., Huisjes A.J., Franx A., Koopman C., Bots M.L., and Bruinse H.W. A randomised placebo-controlled trial of prolonged prednisolone administration to patients with HELLP syndrome remote from term. Eur J Obstet Gynecol Reprod Biol 128 (2006) 187-193
105. Rose C.H., Thigpen B.D., Bofill J.A., Cushman J., May W.L., and Martin Jr. J.N. Obstetric implications of antepartum corticosteroid therapy for HELLP syndrome. Obstet Gynecol 104 (2004) 1011-1014
106. Katz L., De Amorim M.M.R., Figueiroa J.N., and Pinto e Silva J.L. Postpartum dexamethasone for women with hemolysis, elevated liver enzymes, and low platelets (HELLP) syndrome: a double-blind, placebo-controled, randomized clinical trial. Am J Obstet Gynecol 198 283 (2008) e1-e8
107. Collinet P., Delemer-Lefebvre M., Dharancy S., Lucot J.P., Subtil D., and Puech F. Le HELLP syndrome : diagnostic et prise en charge thérapeutique. Gynecol Obstet Fertil 34 (2006) 94-100
108. Report of the National High Blood Pressure Education Program. Working group report on high blood pressure in pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
109. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynaecol Obstet 2002;77:67-75.
110. Sibai B.M. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 102 (2003) 181-192
111. Rozenberg P. Intérêt du sulfate de magnésium dans la prise en charge de la prééclampsie. Gynecol Obstet Fertil 34 (2006) 54-59
112. Girard B., Beucher G., Muris C., Simonet T., and Dreyfus M. Sulfate de magnesium et prééclampsie severe : innocuité en pratique courante dans des indications ciblées. J Gynecol Obstet Biol Reprod 34 (2005) 17-22
113. Roberts W.E., Perry Jr. K.G., Woods J.B., Files J.C., Blake P.G., and Martin Jr. J.N. The intrapartum platelet count in patients with HELLP (hemolysis, elevated liver enzymes and low platelets) syndrome: is it predictive of later hemorrhagic complications?. Am J Obstet Gynecol 171 (1994) 799-804
114. Magann E.F., Roberts W.E., Perry Jr. K.G., Chauhan S.P., Blake P.G., and Martin Jr. J.N. Factors relevant to mode of preterm delivery with HELLP syndrome. Am J Obstet Gynecol 170 (1994) 1828-1834
115. Dreyfus M., Tissier I., Baldauff, and Ritter J. HELLP syndrome : Revue et mise à jour. J Gynecol Obstet Reprod Biol 26 (1997) 9-15
116. SFAR. Les blocs périmédullaires chez l'adulte, RPC, 2006. http://www.sfar.org.
117. Martin Jr. J.N., Files J.C., Blake P.G., Perry Jr. K.G., Morrison J.C., and Norman P.H. Postpartum plasma exchange for atypical preeclampsia-eclampsia as HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 172 (1995) 1107-1125
118. Eser B., Guven M., Unal A., Coskun R., Altuntas F., Sungur M., et al. The role of plasma exchange in HELLP syndrome. Clin Appl Thromb Hemost 11 (2005) 211-217
119. Knapen M.F., Van Altena A.M., Peters W.H., Merkus H.M., Jansen J.B., and Steegers E.A. Liver function following pregnancy complicated by the HELLP syndrome. Br J Obstet Gynaecol 105 (1998) 1208-1210
120. Sullivan C.A., Magann E.F., Perry K.G., Roberts W.E., Blake P.G., and Martin Jr. J.N. The recurrence risk of the syndrome of hemolysis, elevated liver enzymes, and low platelets (HELLP) in subsequent gestations. Am J Obstet Gynecol 171 (1994) 940-943
121. Sibaï B.M., Ramadan M.K., Chari R.S., and Friedman S.A. Pregnancies complicated by HELLP syndrome (hemolysis, elevated liver enzymes, and low platelets): subsequent pregnancy outcome and long-term prognosis. Am J Obstet Gynecol 172 (1995) 125-129
122. Van Pampus M.G., Wolf H., Mayruhu G., Treffers P.E., and Bleker O.P. Long-term follow-up in patients with a history of (H)ELLP syndrome. Hypertens Pregnancy 20 (2001) 15-23
123. Chames M.C., Haddad B., Barton J.R., Livingston J.C., and Sibai B.M. Subsequent pregnancy outcome in women with a history of HELLP syndrome at